What is he best known for?
The fields of study he is best known for:
Bioluminescence imaging, Virology, Cell biology, Cancer research and Luciferase are his primary areas of study.
His Virology study frequently draws parallels with other fields, such as Immune system.
His study in the fields of Proteasome inhibitor under the domain of Cell biology overlaps with other disciplines such as Bortezomib.
His studies deal with areas such as Cancer, Multiple drug resistance, CXCL2, Chemokine receptor and Pathology as well as Cancer research.
The study incorporates disciplines such as Vaccinia and Bioluminescence in addition to Luciferase.
His Herpes simplex virus research is multidisciplinary, relying on both Innate immune system and Alpha interferon.
His most cited work include:
- Herpes simplex virus type 1 activates murine natural interferon-producing cells through toll-like receptor 9. (621 citations)
- Herpes simplex virus type 1 activates murine natural interferon-producing cells through toll-like receptor 9. (621 citations)
- Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy. (619 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Cancer research, Cancer, Cell biology, Cancer cell and Metastasis.
In his study, Kinase is strongly linked to PI3K/AKT/mTOR pathway, which falls under the umbrella field of Cancer research.
His Cancer course of study focuses on Bioluminescence imaging and Viral pathogenesis and Virus.
His work in Cell biology addresses issues such as Chemokine, which are connected to fields such as Chemotaxis and Signal transduction.
His research in Cancer cell intersects with topics in Spheroid, Extracellular matrix and Stromal cell.
The various areas that he examines in his Metastasis study include Tumor progression, Breast cancer, CXCR4 and Pathology.
He most often published in these fields:
- Cancer research (22.12%)
- Cancer (18.14%)
- Cell biology (17.70%)
What were the highlights of his more recent work (between 2017-2021)?
- Cancer cell (16.37%)
- Cancer research (22.12%)
- Cancer (18.14%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Cancer cell, Cancer research, Cancer, Text mining and Cell biology.
His Cancer cell research is multidisciplinary, incorporating perspectives in Stromal cell, Protein kinase B, Organoid, Spheroid and Extracellular matrix.
His Cancer research research includes elements of Metastasis, Breast cancer, Triple-negative breast cancer, PI3K/AKT/mTOR pathway and Kinase.
His work carried out in the field of Metastasis brings together such families of science as Tumor progression, Transcriptome and Cell migration.
His work investigates the relationship between Cancer and topics such as Medical physics that intersect with problems in Cancer prevention.
Gary D. Luker combines subjects such as Glycolysis, Receptor and Fluorescence-lifetime imaging microscopy with his study of Cell biology.
Between 2017 and 2021, his most popular works were:
- Targeting Breast Cancer Stem Cell State Equilibrium through Modulation of Redox Signaling. (107 citations)
- Biomaterials-Based Approaches to Tumor Spheroid and Organoid Modeling (38 citations)
- Hybrid collagen alginate hydrogel as a platform for 3D tumor spheroid invasion (36 citations)
In his most recent research, the most cited papers focused on:
Gary D. Luker focuses on Cancer cell, Cell biology, Cancer research, Metastasis and Extracellular matrix.
The Cancer cell study combines topics in areas such as Stromal cell, Scaffold, 3D cell culture, Proteolytic enzymes and Spheroid.
His work on Intracellular as part of general Cell biology study is frequently linked to Caspase 3, bridging the gap between disciplines.
His Cancer research study also includes
- PI3K/AKT/mTOR pathway that connect with fields like Protein kinase B, Chemokine, Kinase and MAPK/ERK pathway,
- Cell that connect with fields like RHOA and Mesenchymal stem cell.
His Metastasis study results in a more complete grasp of Cancer.
He studies Breast cancer which is a part of Cancer.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
